VanEck has launched a bionic engineering ETF, aiming to invest in companies that create solutions for medical implants or artificial body parts
The ETF is listed on the London Stock Exchange and German stock exchange Xetra. The firm described bionics as the "research and development of approaches for developing technical applications based on the model of living systems," specifically technologies designed to enhance or restore functions of human body. VanEck gave examples that include prosthetics, bio-printed tissues, replacement organs and body function aids. VanEck launches genomics and healthcare innovators ETF Tracking the MVIS Global Bionic Healthcare ESG index, the ETF excludes firms that manufacture devices ...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
